Borrelia Burgdorferi

Total Page:16

File Type:pdf, Size:1020Kb

Load more

Identification and Characterization of Candidate Treponema pallidum Vascular Adhesins by Heterologous Expression in the Lyme Disease Pathogen by Wei-Chien (Andrew) Kao A thesis submitted in conformity with the requirements for the degree of Master of Science Faculty of Dentistry University of Toronto © Copyright by Wei-Chien (Andrew) Kao 2016 Identification and characterization of candidate Treponema pallidum vascular adhesins by heterologous expression in the Lyme disease pathogen Wei-Chien (Andrew) Kao Master of Science Faculty of Dentistry University of Toronto 2016 Abstract This thesis reports novel techniques to study the candidate adhesin of unculturable syphilis pathogen Treponema pallidum in the Lyme disease pathogen Borrelia burgdorferi. The Treponema pallidum laminin-binding adhesin, Tp0751, was heterologously expressed and surface localized in a non-infectious, less-adherent B. burgdorferi strain which has the attenuated ability to interact with cultured mammalian cells in vitro and vascular endothelial cells in vivo. By using the flow chamber techniques and intravital microscopy approach, I demonstrated that Tp0751 was able to restore borrelial-endothelial interactions in vitro, and was able to confer vascular adhesion in vivo. This study has illustrated that gain-of-function B. burgdorferi strain can serve as a machinery to study the activity of treponemal outer surface proteins. The analysis of the adhesive role of Treponema pallidum will reveal its mechanisms of dissemination and tissue colonization during syphilis infection. ii Table of contents List of diagrams ............................................................................................................................. vi List of figures and tables ............................................................................................................... vii List of abbreviations .................................................................................................................... viii Chapter 1. Introduction and literature review ................................................................................. 1 1.1 Pathogenic spirochetes ..................................................................................................... 1 1.1.1 Borrelia burgdorferi ................................................................................................. 2 1.1.2 Treponema pallidum ............................................................................................... 14 1.2 Production of outer membrane lipoproteins in B. burgdorferi and T. pallidum ............ 19 1.2.1 Secretion and localization of lipoproteins in other gram-negative bacteria ........... 20 1.2.2 Current knowledge of lipoproteins secretion and localization in B. burgdorferi and T. pallidum .............................................................................................................. 21 1.3 Strategy utilized to characterize B. burgdorferi vascular adhesins ................................ 22 1.3.1 In vivo phage display to identify potential adhesins ............................................... 22 1.3.2 Generation of gain-of-function and loss-of function strains to measure the cell- and ligand-binding activity promoted by the adhesins .................................................. 23 1.3.3 Flow-chamber imaging to determine bacterial-endothelial interaction under the environment with fluid shear stress ........................................................................ 23 1.3.4 Imaging techniques including intravital microscapy (IVM) and whole body imaging to observe spirochetal colonization and dissemination in vivo ................. 24 1.3.5 Short-term intravenous infection model to measure vascular interaction promoted by the adhesins ........................................................................................................ 25 1.4 Rationale, objective and hypothesis of M.Sc. studies .................................................... 26 Chapter 2. Manuscript - Heterologous expression of the Treponema pallidum vascular adhesin Tp0751 in the Lyme disease pathogen Borrelia burgdorferi ....................................................... 27 2.1 Abstract .......................................................................................................................... 27 2.2 Introduction .................................................................................................................... 27 2.3 Materials and methods ................................................................................................... 30 2.4 Results ............................................................................................................................ 43 2.5 Discussion ...................................................................................................................... 51 2.6 Figures and tables ........................................................................................................... 56 iii 2.7 Supplemental movies ..................................................................................................... 85 Chapter 3. Thesis discussion ......................................................................................................... 86 References ..................................................................................................................................... 90 iv Original contribution to science I completed all experimental work and writing associated with this thesis except: Chapter 2 (Manuscript): Introduction, figures, legends, first half of results drafted/written with/by Helena Pětrošová and rewritten by me Experiments and analysis for following figures were conducted by others: o Fig. 1A: Collaborator Rebecca Hof (Cameron lab) generated gain-of-function constructs, and I transformed them into Borrelia o Fig. 1B-C: FACS analysis of protein expression and localization performed by collaborator Yi-Pin Lin (Leong lab) o Fig. 2A: Collaborator Karen Lithgow (Cameron lab) performed static adhesion assays o Fig. 6A: Intravital microscopy was performed with assistance of collaborator Pablo Rojas (Moter lab) o Fig. 6B: Co-author Yang (Shirley) Zhang (Moriarty lab) performed qPCR to measure bacterial burden in blood o Fig. S1: Collaborator Charmaine Wetherell (Cameron lab) performed Tp0751 PCR screening o Fig. S2: Co-author Rhodaba Ebady (Moriarty lab) performed all experiments for GCB1586 (RevB), tracking and analysis for this figure v List of diagrams Page Diagram 1. The natural infectious cycle of Borrelia burgdorferi 2 Diagram 2. The course of Borrelia burgdorferi infection and Lyme disease in humans 3 vi List of figures and tables Page Figure 1. Surface production of Tp0751 in transformed B. burgdorferi strains 56 Figure 2. Interaction of Tp0751-expressing strains with human endothelia under static and 58 physiological shear stress conditions Figure 3. Physical properties of B. burgdorferi interactions mediated by Tp0751 60 Figure 4. Effect of Tp0751 on tether-dependent and tether-independent interactions 62 Figure 5. Effect of increasing shear stress on physical properties of Tp0751-dependent 64 interactions Figure 6. Interaction of Tp0751-expressing strains with vasculature in vivo 66 Figure S1. PCR screening of Tp0751-expressing strains, showing the presence of Tp0751 68 insert, pTM259 and pTM61 plasmids Figure S2. Effect of FLAG-tag in bacterial interactions under physiological shear force 70 Figure S3. Dissociation kinetics of tether-dependent and tether-independent interactions 72 under physiological fluid shear force Figure S4. B. burgdorferi interaction trajectories of tether-dependent interactions 74 Figure S5. B. burgdorferi interaction trajectories of tether-independent interactions 76 Figure S6. Secondary structure prediction of BBK32 and Tp0751 78 Table S1. B. burgdorferi strains used in this study 80 Table S2. Constructs used in this study 81 Table S3. Primers used in this study 82 Table S4. Bacterial length of individual B. burgdorferi strains 84 vii List of abbreviations BSK II Barbour-Stoenner-Kelly II CRASP Complement regulator-acquiring surface protein DB Dextrose and BSA ECM Extracellular matrix ELISA Enzyme-linked immunosorbent assay FACS Fluorescence-activated cell sorting Fb Force imposed on the bonds FBS Fetal bovine serum Fn Fibronectin GAG Glycosaminoglycan GFP Green fluorescent protein HBSC HEPES buffer with sodium chloride and calcium chloride HIV Human immunodeficiency virus HUVEC Human umbilical vein endothelial cell ICAM-1 Intercellular adhesion molecule 1 iNKT cell Invariant natural killer T cell IVM Intravital microscopy Koff Dissociation rate constant Lol pathway Lipoprotein outer membrane localization pathway MFI Mean fluorescence index pFn Plasma fibronectin qPCR Quantitative PCR Sec pathway Secretory pathway SRP Signal recognition particle TAT pathway Twin-arginine translocation pathway VCAM-1 Vascular cell adhesion molecule 1 viii Chapter 1. Introduction and literature review 1.1 Pathogenic spirochetes Spirochetes belong to a phylum of a large group of morphologically unique bacteria which are widespread in aquatic environments and in animals (Paster and Dewhirst, 2000). They possess unique spiral shapes with length and diameter ranging from 5 to 250μm and 0.1 to 0.5μm, respectively (Pavia, 1994). Unlike other bacteria, spirochetes utilize periplasmic flagella located in the periplasm to promote their motility (Wolgemuth, 2015). During early infection, spirochetes
Recommended publications
  • LYME DISEASE Other Names: Borrelia Burgdorferi

    LYME DISEASE Other Names: Borrelia Burgdorferi

    LYME DISEASE Other names: Borrelia burgdorferi CAUSE Lyme disease is caused by a spirochete bacteria (Borrelia burgdorferi) that is transmitted through the bite from an infected arthropod vector, the black-legged or deer tick Ixodes( scapularis). SIGNIFICANCE Lyme disease can infect people and some species of domestic animals (cats, dogs, horses, and cattle) causing mild to severe illness. Although wildlife can be infected by the bacteria, it typically does not cause illness in them. TRANSMISSION The bacteria has been observed in the blood of a number of wildlife species including several bird species but rarely appears to cause illness in these species. White-footed mice, eastern chipmunks, and shrews serve as the primary natural reservoirs for Lyme disease in eastern and central parts of North America. Other species appear to have low competencies as reservoirs for the bacteria. The transmission of Lyme disease is relatively convoluted due to the complex life cycle of the black-legged tick. This tick has multiple developmental stages and requires three hosts during its life cycle. The life cycle begins with the eggs of the ticks that are laid in the spring and from which larval ticks emerge. Larval ticks do not initially carryBorrelia burgdorferi, the bacteria must be acquired from their hosts they feed upon that are carriers of the bacteria. Through the summer the larval ticks feed on the blood of their first host, typically small mammals and birds. It is at this point where ticks may first acquireBorrelia burgdorferi. In the fall the larval ticks develop into nymphs and hibernate through the winter.
  • Differences in Genotype, Clinical Features, and Inflammatory

    Differences in Genotype, Clinical Features, and Inflammatory

    RESEARCH Differences in Genotype, Clinical Features, and Inflammatory Potential of Borrelia burgdorferi sensu stricto Strains from Europe and the United States Tjasa Cerar,1 Franc Strle,1 Dasa Stupica, Eva Ruzic-Sabljic, Gail McHugh, Allen C. Steere, Klemen Strle Borrelia burgdorferi sensu stricto isolates from patients with B. afzelii, which usually remains localized to the skin, with erythema migrans in Europe and the United States and B. garinii, which is usually associated with nervous were compared by genotype, clinical features of infection, system involvement (1). B. burgdorferi infection is rare in and inflammatory potential. Analysis of outer surface pro- Europe; little is known about its clinical course there. In tein C and multilocus sequence typing showed that strains the United States, B. burgdorferi is the sole agent of Lyme from these 2 regions represent distinct genotypes. Clinical borreliosis; in the northeastern United States, it is particu- features of infection with B. burgdorferi in Slovenia were similar to infection with B. afzelii or B. garinii, the other 2 larly arthritogenic (1,2). For all 3 species, the first sign of Borrelia spp. that cause disease in Europe, whereas B. infection is often an erythema migrans lesion. However, B. burgdorferi strains from the United States were associ- burgdorferi infection in the United States is associated with ated with more severe disease. Moreover, B. burgdorferi a greater number of disease-associated symptoms and more strains from the United States induced peripheral blood frequent hematogenous dissemination than B. afzelii or B. mononuclear cells to secrete higher levels of cytokines garinii infection in Europe (4–7).
  • Canine Lyme Borrelia

    Canine Lyme Borrelia

    Canine Lyme Borrelia Borrelia burgdorferi bacteria are the cause of Lyme disease in humans and animals. They can be visualized by darkfild microscopy as "corkscrew-shaped" motile spirochetes (400 x). Inset: The black-legged tick, lxodes scapularis (deer tick), may carry and transmit Borrelia burgdorferi to humans and animals during feeding, and thus transmit Lyme disease. Samples: Blood EDTA-blood as is, purple-top tubes or EDTA-blood preserved in sample buffer (preferred) Body fluids Preserved in sample buffer Notes: Send all samples at room temperature, preferably preserved in sample buffer MD Submission Form Interpretation of PCR Results: High Positive Borrelia spp. infection (interpretation must be correlated to (> 500 copies/ml swab) clinical symptoms) Low Positive (<500 copies/ml swab) Negative Borrelia spp. not detected Lyme Borreliosis Lyme disease is caused by spirochete bacteria of a subgroup of Borrelia species, called Borrelia burgdorferi sensu lato. Only one species, B. burgdorferi sensu stricto, is known to be present in the USA, while at least four pathogenic species, B. burgdorferi sensu stricto, B. afzelii, B. garinii, B. japonica have been isolated in Europe and Asia (Aguero- Rosenfeld et al., 2005). B. burgdorferi sensu lato organisms are corkscrew-shaped, motile, microaerophilic bacteria of the order Spirochaetales. Hard-shelled ticks of the genus Ixodes transmit B. burgdorferi by attaching and feeding on various mammalian, avian, and reptilian hosts. In the northeastern states of the US Ixodes scapularis, the black-legged deer tick, is the predominant vector, while at the west coast Lyme borreliosis is maintained by a transmission cycle which involves two tick species, I.
  • Investigation of the Lipoproteome of the Lyme Disease Bacterium

    Investigation of the Lipoproteome of the Lyme Disease Bacterium

    INVESTIGATION OF THE LIPOPROTEOME OF THE LYME DISEASE BACTERIUM BORRELIA BURGDORFERI BY Alexander S. Dowdell Submitted to the graduate degree program in Microbiology, Molecular Genetics & Immunology and the Graduate Faculty of the University of Kansas in partial fulfillment of the requirements for the degree of Doctor of Philosophy. _____________________________ Wolfram R. Zückert, Ph.D., Chairperson _____________________________ Indranil Biswas, Ph.D. _____________________________ Mark Fisher, Ph.D. _____________________________ Joe Lutkenhaus, Ph.D. _____________________________ Michael Parmely, Ph.D. Date Defended: April 27th, 2017 The dissertation committee for Alexander S. Dowdell certifies that this is the approved version of the following dissertation: INVESTIGATION OF THE LIPOPROTEOME OF THE LYME DISEASE BACTERIUM BORRELIA BURGDORFERI _____________________________ Wolfram R. Zückert, Ph.D., Chairperson Date Approved: May 4th, 2017 ii Abstract The spirochete bacterium Borrelia burgdorferi is the causative agent of Lyme borreliosis, the top vector-borne disease in the United States. B. burgdorferi is transmitted by hard- bodied Ixodes ticks in an enzootic tick/vertebrate cycle, with human infection occurring in an accidental, “dead-end” fashion. Despite the estimated 300,000 cases that occur each year, no FDA-approved vaccine is available for the prevention of Lyme borreliosis in humans. Development of new prophylaxes is constrained by the limited understanding of the pathobiology of B. burgdorferi, as past investigations have focused intensely on just a handful of identified proteins that play key roles in the tick/vertebrate infection cycle. As such, identification of novel B. burgdorferi virulence factors is needed in order to expedite the discovery of new anti-Lyme therapeutics. The multitude of lipoproteins expressed by the spirochete fall into one such category of virulence factor that merits further study.
  • Assessing Lyme Disease Relevant Antibiotics Through Gut Bacteroides Panels

    Assessing Lyme Disease Relevant Antibiotics Through Gut Bacteroides Panels

    Assessing Lyme Disease Relevant Antibiotics through Gut Bacteroides Panels by Sohum Sheth Abstract: Lyme borreliosis is the most prevalent vector-borne disease in the United States caused by the transmission of bacteria Borrelia burgdorferi harbored by the Ixodus scapularis ticks (Sharma, Brown, Matluck, Hu, & Lewis, 2015). Antibiotics currently used to treat Lyme disease include oral doxycycline, amoxicillin, and ce!riaxone. Although the current treatment is e"ective in most cases, there is need for the development of new antibiotics against Lyme disease, as the treatment does not work in 10-20% of the population for unknown reasons (X. Wu et al., 2018). Use of antibiotics in the treatment of various diseases such as Lyme disease is essential; however, the downside is the development of resistance and possibly deleterious e"ects on the human gut microbiota composition. Like other organs in the body, gut microbiota play an essential role in the health and disease state of the body (Ianiro, Tilg, & Gasbarrini, 2016). Of importance in the microbiome is the genus Bacteroides, which accounts for roughly one-third of gut microbiome composition (H. M. Wexler, 2007). $e purpose of this study is to investigate how antibiotics currently used for the treatment of Lyme disease in%uences the Bacteroides cultures in vitro and compare it with a new antibiotic (antibiotic X) identi&ed in the laboratory to be e"ective against B. burgdorferi. Using microdilution broth assay, minimum inhibitory concentration (MIC) was tested against nine di"erent strains of Bacteroides. Results showed that antibiotic X has a higher MIC against Bacteroides when compared to amoxicillin, ce!riaxone, and doxycycline, making it a promising new drug for further investigation and in vivo studies.
  • Borrelia Burgdorferi Surface Exposed Groel Is a Multifunctional Protein

    Borrelia Burgdorferi Surface Exposed Groel Is a Multifunctional Protein

    pathogens Article Borrelia burgdorferi Surface Exposed GroEL Is a Multifunctional Protein Thomas Cafiero and Alvaro Toledo * Department of Entomology, Rutgers University, New Brunswick, NJ 08901, USA; tcafi[email protected] * Correspondence: [email protected]; Tel.: +1-848-932-0955 Abstract: The spirochete, Borrelia burgdorferi, has a large number of membrane proteins involved in a complex life cycle, that includes a tick vector and a vertebrate host. Some of these proteins also serve different roles in infection and dissemination of the spirochete in the mammalian host. In this spirochete, a number of proteins have been associated with binding to plasminogen or components of the extracellular matrix, which is important for tissue colonization and dissemination. GroEL is a cytoplasmic chaperone protein that has previously been associated with the outer membrane of Borrelia. A His-tag purified B. burgdorferi GroEL was used to generate a polyclonal rabbit antibody showing that GroEL also localizes in the outer membrane and is surface exposed. GroEL binds plasminogen in a lysine dependent manner. GroEL may be part of the protein repertoire that Borrelia successfully uses to establish infection and disseminate in the host. Importantly, this chaperone is readily recognized by sera from experimentally infected mice and rabbits. In summary, GroEL is an immunogenic protein that in addition to its chaperon role it may contribute to pathogenesis of the spirochete by binding to plasminogen and components of the extra cellular matrix. Keywords: Borrelia burgdorferi; Lyme disease; GroEL; Moonlight protein Citation: Cafiero, T.; Toledo, A. Borrelia burgdorferi Surface Exposed 1. Introduction GroEL Is a Multifunctional Protein. Pathogens 2021, 10, 226.
  • Values of Diagnostic Tests for the Various Species of Spirochetes

    Values of Diagnostic Tests for the Various Species of Spirochetes

    +Model MEDMAL-4093; No. of Pages 10 ARTICLE IN PRESS Disponible en ligne sur ScienceDirect www.sciencedirect.com Médecine et maladies infectieuses xxx (2019) xxx–xxx Review Values of diagnostic tests for the various species of spirochetes Performances des tests diagnostiques pour les différentes espèces de spirochètes a,∗ b a c,d e Carole Eldin , Benoit Jaulhac , Oleg Mediannikov , Jean-Pierre Arzouni , Didier Raoult a IRD, AP–HM, SSA, VITROME, IHU-Méditerranée Infection, Aix Marseille Université, 13005 Marseille, France b Laboratoire de bactériologie, Centre national de référence des Borrelia, faculté de médecine de Strasbourg, hôpitaux universitaires de Strasbourg, 67091 Strasbourg, France c Plate-forme de sérologie bactérienne, IHU-Méditerranée Infection, 13005 Marseille, France d Labosud provence biologie, 13117 Martigues, France e IRD, AP–HM, MEPHI, IHU-Méditerranée Infection, Aix Marseille Université, 13005 Marseille, France Received 26 October 2018; accepted 21 January 2019 Abstract Bacteria of the Borrelia burgdorferi sensu lato complex, responsible for Lyme disease, are members of the spirochetes phylum. Diagnostic difficulties of Lyme disease are partly due to the characteristics of spirochetes as their culture is tedious or even impossible for some of them. We performed a literature review to assess the value of the various diagnostic tests of spirochetes infections of medical interest such as Lyme borreliosis, relapsing fever borreliae, syphilis, and leptospirosis. We were able to draw similarities between these four infections. Real-time PCR now plays an important role in the direct diagnosis of these infections. However, direct diagnosis remains difficult because of a persistent lack of sensitivity. Serological testing is therefore crucial in the diagnostic process.
  • Clinical Spectrum of Lyme Disease

    Clinical Spectrum of Lyme Disease

    European Journal of Clinical Microbiology & Infectious Diseases (2019) 38:201–208 https://doi.org/10.1007/s10096-018-3417-1 REVIEW Clinical spectrum of Lyme disease Jesus Alberto Cardenas-de la Garza1 & Estephania De la Cruz-Valadez1 & Jorge Ocampo-Candiani 1 & Oliverio Welsh1 Received: 4 September 2018 /Accepted: 30 October 2018 /Published online: 19 November 2018 # Springer-Verlag GmbH Germany, part of Springer Nature 2018 Abstract Lyme disease (borreliosis) is one of the most common vector-borne diseases worldwide. Its incidence and geographic expansion has been steadily increasing in the last decades. Lyme disease is caused by Borrelia burgdorferi sensu lato, a heterogeneous group of which three genospecies have been systematically associated to Lyme disease: B. burgdorferi sensu stricto Borrelia afzelii and Borrelia garinii. Geographical distribution and clinical manifestations vary according to the species involved. Lyme disease clinical manifestations may be divided into three stages. Early localized stage is characterized by erythema migrans in the tick bite site. Early disseminated stage may present multiple erythema migrans lesions, borrelial lymphocytoma, lyme neuroborreliosis, carditis, or arthritis. The late disseminated stage manifests with acordermatitis chronica atrophicans, lyme arthritis, and neurological symptoms. Diagnosis is challenging due to the varied clinical manifestations it may present and usually involves a two-step serological approach. In the current review, we present a thorough revision of the clinical manifestations Lyme disease may present. Additionally, history, microbiology, diagnosis, post-treatment Lyme disease syndrome, treatment, and prognosis are discussed. Keywords Lyme disease . Borrelia burgdorferi . Tick-borne diseases . Ixodes . Erythema migrans . Lyme neuroborreliosis History posteriorly meningitis, establishing a link between both mani- festations.
  • Lyme Disease Borrelia Burgdorferi Anaplasmosis Anaplasma

    Lyme Disease Borrelia Burgdorferi Anaplasmosis Anaplasma

    TICKBORNE DISEASES IN MICHIGAN: A REFERENCE FOR HEALTH CARE PROVIDERS Lyme disease Anaplasmosis Borrelia burgdorferi Anaplasma phagocytophillum Blacklegged (deer) tick Blacklegged (deer) tick Vector Incubation Period 3 – 30 days 1 – 2 weeks Early localized disease: • Characteristic erythema migrans (EM) rash . Fever, chills • Fever & chills . Severe headache • Headache . Malaise • Myalgia & arthralgia . Myalgia • Lymphadenopathy . Gastrointestinal symptoms Signs and Disseminated disease (weeks to months after . Cough Symptoms exposure): . Rash (rare cases) • Multiple EM lesions . Stiff neck* • Nervous system abnormalities including nerve . Confusion* paralysis (facial muscles), meningitis • Arthritis in large joints, especially the knee *May present later (5 days after onset of symptoms) • Myocarditis, pericarditis, or atrioventricular node and may be prevented by early treatment block Typically observed during the first week of clinical disease: • Mild anemia • Elevated erythrocyte sedimentation rate • Thrombocytopenia • Mildly elevated hepatic transaminases General • Leukopenia (characterized by relative and absolute • Microscopic hematuria or proteinuria lymphopenia and a left shift) Laboratory • In Lyme meningitis, CSF typically shows • Mild to moderate elevations in hepatic Findings lymphocytic pleocytosis, slightly elevated transaminases may occur in some patients protein, and normal glucose • Visualization of morulae in the cytoplasm of granulocytes is highly suggestive of a diagnosis; however, blood smear examination is insensitive. Antibodies to A. phagocytophillum are detectable 7- • Demonstration of diagnostic IgM or IgG 10 days after illness onset. antibodies in serum. A two-tier testing protocol • Demonstration of a four-fold change in IgG-specific is recommended – EIA or IFA should be antibody titer by IFA test in paired serum samples; Laboratory performed first; if positive or equivocal it is or followed by a Western blot.
  • Borrelia Burgdorferi)

    Borrelia Burgdorferi)

    The Lyme Bacterium (Borrelia burgdorferi) Habitat : Called an endoparasite, this bacterium can only live inside of another organism. Remarkably, B. burgforferi can survive in a range of temperatures, from the hemolymph of insects to the warm blood of mammals. Diet : B. burgforferi obtains nutrients and energy from the blood of a host. Life Cycle/Reproduction: B. burgforferi reproduces asexually, making identical copies of itself with each duplication. They can reproduce rapidly, and one scientific study found an average of 2,735 bacteria/tick 15 days after the tick had fed. Although the scientists found that recently molted nymphs had only 300 bacteria/nymph, within 75 days, these nymphs had an average of 61,275 bacteria! The tick serves as the vector for the bacteria, moving it from one “holding place” or “reservoir” to another host, which may even be a human. Small rodents, especially mice, act as good reservoirs. If a larva bites an infected mouse, that tick will likely become infected itself. The tick vector can then bite another host and transmit the bacteria, propagating itself. Dispersal: There are two types of dispersal associated with this bacterium. First, there is dispersal of individual bacteria. For example within the tick, the bacteria attach to the mid-gut to avoid being digested by the tick. When the tick attaches to a vertebrate host, the bacteria detach from the mid-gut and migrate to the salivary glands, where they can then be transmitted to the vertebrate host. Secondly, there is dispersal of the entire population of bacteria. This type of dispersal requires that the bacteria successfully “move” from a reservoir to a host with the help of a vector.
  • Borrelia Burgdorferi Igg, Igm Fully Automated Chemiluminescence Assays for an Accurate Detection of Igg and Igm Antibodies to Borrelia Burgdorferi

    Borrelia Burgdorferi Igg, Igm Fully Automated Chemiluminescence Assays for an Accurate Detection of Igg and Igm Antibodies to Borrelia Burgdorferi

    Infectious Disease Borrelia burgdorferi IgG, IgM Fully automated chemiluminescence assays for an accurate detection of IgG and IgM antibodies to Borrelia Burgdorferi FOR OUTSIDE THE US AND CANADA ONLY Infectious Disease Borrelia burgdorferi IgG, IgM Searching for diagnostic clarity: Unique selection of raw materials LIAISON® Borrelia serology line The diagnosis of Lyme borreliosis is based on clinical The LIAISON® Borrelia assays are based on recombinant proteins manifestations and history of exposure to ticks in an endemic that allow reduction of cross-reactivity problems providing area. Clinical manifestation of Lyme borreliosis may be similar higher specificity in comparison with whole-cell lysate assays. to that of other diseases, and serological detection of Borrelia The use of immunodominant Borrelia antigens, VIsE for IgG antibodies represents a fundamental aid to diagnosis (Fig.1). assay, OspC and VlsE for IgM assay, has improved the diagnostic sensitivity in all stages of Lyme infection. Tests with high diagnostic accuracy are particularly important for differential diagnosis since additional factors complicate • LIAISON® Borrelia IgG features the antigen VlsE, an serological findings: outer surface lipoprotein playing a major role in the immune response to Lyme disease and leading to decisive • early stage of infection may not show a measurable immune increase of sensitivity in neuroborreliosis (NB). The response VlsE antigen is poorly represented in whole-cell lysate obtained from in vitro cultured B. burgdorferi. • IgM antibodies may persist for months • LIAISON® Borrelia IgM II uses two recombinant antigens: • cross-reaction with other spirochaete proteins, or other OspC, an outer surface protein highly specific for infectious diseases or autoimmune disorders may cause IgM detection in the early phase of infection, and the false positive antibody response VlsE protein.
  • Lyme Disease

    Lyme Disease

    MEDICAL DIAGNOSTIC LABORATORIES, L.L.C. Lyme Disease INTRODUCTION EPIDEMIOLOGY Early in the 20th century, European physicians observed Lyme disease (LD), caused by infection with Borrelia patients with a red, slowly expanding rash called erythema burgdorferi, is the most common vector-borne disease in the migrans (EM) (Figure 1) (1). They associated this rash with United States, accounting for more than 95% of all reported the bite of ticks and postulated that EM was caused by a tick- vector-borne illnesses. From 2003-2005, 64,382 cases of borne bacterium. In the 1940s, a similar tick-borne illness Lyme disease were reported to the CDC from 46 states and was described that often began with EM and developed into the District of Columbia (2). However, a considerable level a multi-system illness. In 1969, a physician in Wisconsin of underreporting is associated with Lyme Disease and, diagnosed a patient with EM and successfully treated the therefore, the true number of infected individuals is probably individual with penicillin. In 1975, a women in Old Lyme, greater. Of the reported cases, 59,770 occurred within ten Connecticut contacted the state health authorities to ask why endemic states: Connecticut, Delaware, Maine, Maryland, so many children in her town had arthritis. She was alarmed Minnesota, New Jersey, New York, Pennsylvania, Rhode by the fact that 12 cases of juvenile arthritis, a relatively rare Island and Wisconsin (2). Within these endemic states, disease, had been diagnosed in a town with a population of the average annual rate of infection over this three year only 5,000.